aluates Reports

$ 0.0

Automative

Global Type 2 Diabetes Medicines Market Research Report 2024

Published Date: April 2024

Report Code: QYRE-Auto-6Y17243

BUY CHAPTERS

Global Type 2 Diabetes Medicines Market Research Report 2024

Code: QYRE-Auto-6Y17243

Report

April 2024

Pages:93

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Novo Nordisk

Sanofi

Eli Lilly

Merck

Astrazeneca plc

Bayer

Boehringer Ingelheim

Johnson & Johnson

Takeda

Tonghua Dongbao

United Pharmaceuticals

Ganli Pharmaceutical

Biocon Ltd.

Conker Pharmaceuticals

Jiangsu Wanbang

Geropharm

WOCKHARDT

Merck Serono

Novartis

Type 2 Diabetes Medicines Market

Diabetes Medicines are treatments for diabetes by lowering the sugar lower in the blood. Diabetes is a kind of disease with common symptoms such as frequent urination, increased thirst and weight loss. Type 2 diabetes, the most common type of diabetes, is a disease that occurs when your blood glucose, also called blood sugar, is too high. The most common medicines used are insulin injection and oral hypoglycemic medications.

The global Type 2 Diabetes Medicines market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.

Type 2 diabetes, the most common type of diabetes, is a disease that occurs when your blood glucose, also called blood sugar, is too high. Blood glucose is your main source of energy and comes mainly from the food you eat.Insulin, ahormonemade by thepancreas, helps glucose get into your cells to be used for energy. In type 2 diabetes, your body doesn’t make enough insulin or doesn’t use insulin well. Too much glucose then stays in your blood, and not enough reaches your cells.Type 2 diabetes, the most common type of diabetes, is a disease that occurs when your blood glucose, also called blood sugar, is too high. Blood glucose is your main source of energy and comes mainly from the food you eat. Insulin, a hormone made by the pancreas, helps glucose get into your cells to be used for energy. In type 2 diabetes, your body doesn’t make enough insulin or doesn’t use insulin well. Too much glucose then stays in your blood, and not enough reaches your cells.

This report aims to provide a comprehensive presentation of the global market for Type 2 Diabetes Medicines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Type 2 Diabetes Medicines.

The Type 2 Diabetes Medicines market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Type 2 Diabetes Medicines market comprehensively. Regional market sizes, concerning products by Type, by Channel, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Type 2 Diabetes Medicines companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Channel, and by regions.

Market Segmentation

Scope of Type 2 Diabetes Medicines Market Report

Report Metric	Details
Report Name	Type 2 Diabetes Medicines Market
Segment by Type	Oral Hypoglycemic Medications Insulin Injection
Segment by Channel	Hospital Retail Pharmacy
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Novo Nordisk, Sanofi, Eli Lilly, Merck, AstraZeneca, bayer, Boehringer Ingelheim, Johnson & Johnson, Takeda, Tonghua Dongbao, United Pharmaceuticals, Ganli Pharmaceutical, Biocon, Conker Pharmaceuticals, Jiangsu Wanbang, Geropharm, Wockhardt, Merck Serono, Novartis
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Channel, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Type 2 Diabetes Medicines company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Channel, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Type 2 Diabetes Medicines Market report?

Ans: The main players in the Type 2 Diabetes Medicines Market are Novo Nordisk, Sanofi, Eli Lilly, Merck, AstraZeneca, bayer, Boehringer Ingelheim, Johnson & Johnson, Takeda, Tonghua Dongbao, United Pharmaceuticals, Ganli Pharmaceutical, Biocon, Conker Pharmaceuticals, Jiangsu Wanbang, Geropharm, Wockhardt, Merck Serono, Novartis

What are the Type segmentation covered in the Type 2 Diabetes Medicines Market report?

Ans: The Types covered in the Type 2 Diabetes Medicines Market report are Oral Hypoglycemic Medications, Insulin Injection

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Type 2 Diabetes Medicines Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Oral Hypoglycemic Medications

1.2.3 Insulin Injection

1.3 Market by Channel

1.3.1 Global Type 2 Diabetes Medicines Market Growth by Channel: 2019 VS 2023 VS 2030

1.3.2 Hospital

1.3.3 Retail Pharmacy

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Type 2 Diabetes Medicines Market Perspective (2019-2030)

2.2 Global Type 2 Diabetes Medicines Growth Trends by Region

2.2.1 Global Type 2 Diabetes Medicines Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Type 2 Diabetes Medicines Historic Market Size by Region (2019-2024)

2.2.3 Type 2 Diabetes Medicines Forecasted Market Size by Region (2025-2030)

2.3 Type 2 Diabetes Medicines Market Dynamics

2.3.1 Type 2 Diabetes Medicines Industry Trends

2.3.2 Type 2 Diabetes Medicines Market Drivers

2.3.3 Type 2 Diabetes Medicines Market Challenges

2.3.4 Type 2 Diabetes Medicines Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Type 2 Diabetes Medicines Players by Revenue

3.1.1 Global Top Type 2 Diabetes Medicines Players by Revenue (2019-2024)

3.1.2 Global Type 2 Diabetes Medicines Revenue Market Share by Players (2019-2024)

3.2 Global Type 2 Diabetes Medicines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Type 2 Diabetes Medicines Revenue

3.4 Global Type 2 Diabetes Medicines Market Concentration Ratio

3.4.1 Global Type 2 Diabetes Medicines Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Type 2 Diabetes Medicines Revenue in 2023

3.5 Global Key Players of Type 2 Diabetes Medicines Head office and Area Served

3.6 Global Key Players of Type 2 Diabetes Medicines, Product and Application

3.7 Global Key Players of Type 2 Diabetes Medicines, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Type 2 Diabetes Medicines Breakdown Data by Type

4.1 Global Type 2 Diabetes Medicines Historic Market Size by Type (2019-2024)

4.2 Global Type 2 Diabetes Medicines Forecasted Market Size by Type (2025-2030)

5 Type 2 Diabetes Medicines Breakdown Data by Channel

5.1 Global Type 2 Diabetes Medicines Historic Market Size by Channel (2019-2024)

5.2 Global Type 2 Diabetes Medicines Forecasted Market Size by Channel (2025-2030)

6 North America

6.1 North America Type 2 Diabetes Medicines Market Size (2019-2030)

6.2 North America Type 2 Diabetes Medicines Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Type 2 Diabetes Medicines Market Size by Country (2019-2024)

6.4 North America Type 2 Diabetes Medicines Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Type 2 Diabetes Medicines Market Size (2019-2030)

7.2 Europe Type 2 Diabetes Medicines Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Type 2 Diabetes Medicines Market Size by Country (2019-2024)

7.4 Europe Type 2 Diabetes Medicines Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Type 2 Diabetes Medicines Market Size (2019-2030)

8.2 Asia-Pacific Type 2 Diabetes Medicines Market Growth Rate by Country: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Type 2 Diabetes Medicines Market Size by Region (2019-2024)

8.4 Asia-Pacific Type 2 Diabetes Medicines Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Type 2 Diabetes Medicines Market Size (2019-2030)

9.2 Latin America Type 2 Diabetes Medicines Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Type 2 Diabetes Medicines Market Size by Country (2019-2024)

9.4 Latin America Type 2 Diabetes Medicines Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Type 2 Diabetes Medicines Market Size (2019-2030)

10.2 Middle East & Africa Type 2 Diabetes Medicines Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Type 2 Diabetes Medicines Market Size by Country (2019-2024)

10.4 Middle East & Africa Type 2 Diabetes Medicines Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Novo Nordisk

11.1.1 Novo Nordisk Company Details

11.1.2 Novo Nordisk Business Overview

11.1.3 Novo Nordisk Type 2 Diabetes Medicines Introduction

11.1.4 Novo Nordisk Revenue in Type 2 Diabetes Medicines Business (2019-2024)

11.1.5 Novo Nordisk Recent Development

11.2 Sanofi

11.2.1 Sanofi Company Details

11.2.2 Sanofi Business Overview

11.2.3 Sanofi Type 2 Diabetes Medicines Introduction

11.2.4 Sanofi Revenue in Type 2 Diabetes Medicines Business (2019-2024)

11.2.5 Sanofi Recent Development

11.3 Eli Lilly

11.3.1 Eli Lilly Company Details

11.3.2 Eli Lilly Business Overview

11.3.3 Eli Lilly Type 2 Diabetes Medicines Introduction

11.3.4 Eli Lilly Revenue in Type 2 Diabetes Medicines Business (2019-2024)

11.3.5 Eli Lilly Recent Development

11.4 Merck

11.4.1 Merck Company Details

11.4.2 Merck Business Overview

11.4.3 Merck Type 2 Diabetes Medicines Introduction

11.4.4 Merck Revenue in Type 2 Diabetes Medicines Business (2019-2024)

11.4.5 Merck Recent Development

11.5 AstraZeneca

11.5.1 AstraZeneca Company Details

11.5.2 AstraZeneca Business Overview

11.5.3 AstraZeneca Type 2 Diabetes Medicines Introduction

11.5.4 AstraZeneca Revenue in Type 2 Diabetes Medicines Business (2019-2024)

11.5.5 AstraZeneca Recent Development

11.6 bayer

11.6.1 bayer Company Details

11.6.2 bayer Business Overview

11.6.3 bayer Type 2 Diabetes Medicines Introduction

11.6.4 bayer Revenue in Type 2 Diabetes Medicines Business (2019-2024)

11.6.5 bayer Recent Development

11.7 Boehringer Ingelheim

11.7.1 Boehringer Ingelheim Company Details

11.7.2 Boehringer Ingelheim Business Overview

11.7.3 Boehringer Ingelheim Type 2 Diabetes Medicines Introduction

11.7.4 Boehringer Ingelheim Revenue in Type 2 Diabetes Medicines Business (2019-2024)

11.7.5 Boehringer Ingelheim Recent Development

11.8 Johnson & Johnson

11.8.1 Johnson & Johnson Company Details

11.8.2 Johnson & Johnson Business Overview

11.8.3 Johnson & Johnson Type 2 Diabetes Medicines Introduction

11.8.4 Johnson & Johnson Revenue in Type 2 Diabetes Medicines Business (2019-2024)

11.8.5 Johnson & Johnson Recent Development

11.9 Takeda

11.9.1 Takeda Company Details

11.9.2 Takeda Business Overview

11.9.3 Takeda Type 2 Diabetes Medicines Introduction

11.9.4 Takeda Revenue in Type 2 Diabetes Medicines Business (2019-2024)

11.9.5 Takeda Recent Development

11.10 Tonghua Dongbao

11.10.1 Tonghua Dongbao Company Details

11.10.2 Tonghua Dongbao Business Overview

11.10.3 Tonghua Dongbao Type 2 Diabetes Medicines Introduction

11.10.4 Tonghua Dongbao Revenue in Type 2 Diabetes Medicines Business (2019-2024)

11.10.5 Tonghua Dongbao Recent Development

11.11 United Pharmaceuticals

11.11.1 United Pharmaceuticals Company Details

11.11.2 United Pharmaceuticals Business Overview

11.11.3 United Pharmaceuticals Type 2 Diabetes Medicines Introduction

11.11.4 United Pharmaceuticals Revenue in Type 2 Diabetes Medicines Business (2019-2024)

11.11.5 United Pharmaceuticals Recent Development

11.12 Ganli Pharmaceutical

11.12.1 Ganli Pharmaceutical Company Details

11.12.2 Ganli Pharmaceutical Business Overview

11.12.3 Ganli Pharmaceutical Type 2 Diabetes Medicines Introduction

11.12.4 Ganli Pharmaceutical Revenue in Type 2 Diabetes Medicines Business (2019-2024)

11.12.5 Ganli Pharmaceutical Recent Development

11.13 Biocon

11.13.1 Biocon Company Details

11.13.2 Biocon Business Overview

11.13.3 Biocon Type 2 Diabetes Medicines Introduction

11.13.4 Biocon Revenue in Type 2 Diabetes Medicines Business (2019-2024)

11.13.5 Biocon Recent Development

11.14 Conker Pharmaceuticals

11.14.1 Conker Pharmaceuticals Company Details

11.14.2 Conker Pharmaceuticals Business Overview

11.14.3 Conker Pharmaceuticals Type 2 Diabetes Medicines Introduction

11.14.4 Conker Pharmaceuticals Revenue in Type 2 Diabetes Medicines Business (2019-2024)

11.14.5 Conker Pharmaceuticals Recent Development

11.15 Jiangsu Wanbang

11.15.1 Jiangsu Wanbang Company Details

11.15.2 Jiangsu Wanbang Business Overview

11.15.3 Jiangsu Wanbang Type 2 Diabetes Medicines Introduction

11.15.4 Jiangsu Wanbang Revenue in Type 2 Diabetes Medicines Business (2019-2024)

11.15.5 Jiangsu Wanbang Recent Development

11.16 Geropharm

11.16.1 Geropharm Company Details

11.16.2 Geropharm Business Overview

11.16.3 Geropharm Type 2 Diabetes Medicines Introduction

11.16.4 Geropharm Revenue in Type 2 Diabetes Medicines Business (2019-2024)

11.16.5 Geropharm Recent Development

11.17 Wockhardt

11.17.1 Wockhardt Company Details

11.17.2 Wockhardt Business Overview

11.17.3 Wockhardt Type 2 Diabetes Medicines Introduction

11.17.4 Wockhardt Revenue in Type 2 Diabetes Medicines Business (2019-2024)

11.17.5 Wockhardt Recent Development

11.18 Merck Serono

11.18.1 Merck Serono Company Details

11.18.2 Merck Serono Business Overview

11.18.3 Merck Serono Type 2 Diabetes Medicines Introduction

11.18.4 Merck Serono Revenue in Type 2 Diabetes Medicines Business (2019-2024)

11.18.5 Merck Serono Recent Development

11.19 Novartis

11.19.1 Novartis Company Details

11.19.2 Novartis Business Overview

11.19.3 Novartis Type 2 Diabetes Medicines Introduction

11.19.4 Novartis Revenue in Type 2 Diabetes Medicines Business (2019-2024)

11.19.5 Novartis Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Novo Nordisk

Sanofi

Eli Lilly

Merck

Astrazeneca plc

Bayer

Boehringer Ingelheim

Johnson & Johnson

Takeda

Tonghua Dongbao

United Pharmaceuticals

Ganli Pharmaceutical

Biocon Ltd.

Conker Pharmaceuticals

Jiangsu Wanbang

Geropharm

WOCKHARDT

Merck Serono

Novartis

List of Tables

Table 1. Global Type 2 Diabetes Medicines Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Oral Hypoglycemic Medications

Table 3. Key Players of Insulin Injection

Table 4. Global Type 2 Diabetes Medicines Market Size Growth by Channel (US$ Million): 2019 VS 2023 VS 2030

Table 5. Global Type 2 Diabetes Medicines Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global Type 2 Diabetes Medicines Market Size by Region (2019-2024) & (US$ Million)

Table 7. Global Type 2 Diabetes Medicines Market Share by Region (2019-2024)

Table 8. Global Type 2 Diabetes Medicines Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 9. Global Type 2 Diabetes Medicines Market Share by Region (2025-2030)

Table 10. Type 2 Diabetes Medicines Market Trends

Table 11. Type 2 Diabetes Medicines Market Drivers

Table 12. Type 2 Diabetes Medicines Market Challenges

Table 13. Type 2 Diabetes Medicines Market Restraints

Table 14. Global Type 2 Diabetes Medicines Revenue by Players (2019-2024) & (US$ Million)

Table 15. Global Type 2 Diabetes Medicines Market Share by Players (2019-2024)

Table 16. Global Top Type 2 Diabetes Medicines Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Type 2 Diabetes Medicines as of 2023)

Table 17. Ranking of Global Top Type 2 Diabetes Medicines Companies by Revenue (US$ Million) in 2023

Table 18. Global 5 Largest Players Market Share by Type 2 Diabetes Medicines Revenue (CR5 and HHI) & (2019-2024)

Table 19. Global Key Players of Type 2 Diabetes Medicines, Headquarters and Area Served

Table 20. Global Key Players of Type 2 Diabetes Medicines, Product and Application

Table 21. Global Key Players of Type 2 Diabetes Medicines, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Type 2 Diabetes Medicines Market Size by Type (2019-2024) & (US$ Million)

Table 24. Global Type 2 Diabetes Medicines Revenue Market Share by Type (2019-2024)

Table 25. Global Type 2 Diabetes Medicines Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 26. Global Type 2 Diabetes Medicines Revenue Market Share by Type (2025-2030)

Table 27. Global Type 2 Diabetes Medicines Market Size by Channel (2019-2024) & (US$ Million)

Table 28. Global Type 2 Diabetes Medicines Revenue Market Share by Channel (2019-2024)

Table 29. Global Type 2 Diabetes Medicines Forecasted Market Size by Channel (2025-2030) & (US$ Million)

Table 30. Global Type 2 Diabetes Medicines Revenue Market Share by Channel (2025-2030)

Table 31. North America Type 2 Diabetes Medicines Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 32. North America Type 2 Diabetes Medicines Market Size by Country (2019-2024) & (US$ Million)

Table 33. North America Type 2 Diabetes Medicines Market Size by Country (2025-2030) & (US$ Million)

Table 34. Europe Type 2 Diabetes Medicines Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 35. Europe Type 2 Diabetes Medicines Market Size by Country (2019-2024) & (US$ Million)

Table 36. Europe Type 2 Diabetes Medicines Market Size by Country (2025-2030) & (US$ Million)

Table 37. Asia-Pacific Type 2 Diabetes Medicines Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 38. Asia-Pacific Type 2 Diabetes Medicines Market Size by Region (2019-2024) & (US$ Million)

Table 39. Asia-Pacific Type 2 Diabetes Medicines Market Size by Region (2025-2030) & (US$ Million)

Table 40. Latin America Type 2 Diabetes Medicines Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 41. Latin America Type 2 Diabetes Medicines Market Size by Country (2019-2024) & (US$ Million)

Table 42. Latin America Type 2 Diabetes Medicines Market Size by Country (2025-2030) & (US$ Million)

Table 43. Middle East & Africa Type 2 Diabetes Medicines Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 44. Middle East & Africa Type 2 Diabetes Medicines Market Size by Country (2019-2024) & (US$ Million)

Table 45. Middle East & Africa Type 2 Diabetes Medicines Market Size by Country (2025-2030) & (US$ Million)

Table 46. Novo Nordisk Company Details

Table 47. Novo Nordisk Business Overview

Table 48. Novo Nordisk Type 2 Diabetes Medicines Product

Table 49. Novo Nordisk Revenue in Type 2 Diabetes Medicines Business (2019-2024) & (US$ Million)

Table 50. Novo Nordisk Recent Development

Table 51. Sanofi Company Details

Table 52. Sanofi Business Overview

Table 53. Sanofi Type 2 Diabetes Medicines Product

Table 54. Sanofi Revenue in Type 2 Diabetes Medicines Business (2019-2024) & (US$ Million)

Table 55. Sanofi Recent Development

Table 56. Eli Lilly Company Details

Table 57. Eli Lilly Business Overview

Table 58. Eli Lilly Type 2 Diabetes Medicines Product

Table 59. Eli Lilly Revenue in Type 2 Diabetes Medicines Business (2019-2024) & (US$ Million)

Table 60. Eli Lilly Recent Development

Table 61. Merck Company Details

Table 62. Merck Business Overview

Table 63. Merck Type 2 Diabetes Medicines Product

Table 64. Merck Revenue in Type 2 Diabetes Medicines Business (2019-2024) & (US$ Million)

Table 65. Merck Recent Development

Table 66. AstraZeneca Company Details

Table 67. AstraZeneca Business Overview

Table 68. AstraZeneca Type 2 Diabetes Medicines Product

Table 69. AstraZeneca Revenue in Type 2 Diabetes Medicines Business (2019-2024) & (US$ Million)

Table 70. AstraZeneca Recent Development

Table 71. bayer Company Details

Table 72. bayer Business Overview

Table 73. bayer Type 2 Diabetes Medicines Product

Table 74. bayer Revenue in Type 2 Diabetes Medicines Business (2019-2024) & (US$ Million)

Table 75. bayer Recent Development

Table 76. Boehringer Ingelheim Company Details

Table 77. Boehringer Ingelheim Business Overview

Table 78. Boehringer Ingelheim Type 2 Diabetes Medicines Product

Table 79. Boehringer Ingelheim Revenue in Type 2 Diabetes Medicines Business (2019-2024) & (US$ Million)

Table 80. Boehringer Ingelheim Recent Development

Table 81. Johnson & Johnson Company Details

Table 82. Johnson & Johnson Business Overview

Table 83. Johnson & Johnson Type 2 Diabetes Medicines Product

Table 84. Johnson & Johnson Revenue in Type 2 Diabetes Medicines Business (2019-2024) & (US$ Million)

Table 85. Johnson & Johnson Recent Development

Table 86. Takeda Company Details

Table 87. Takeda Business Overview

Table 88. Takeda Type 2 Diabetes Medicines Product

Table 89. Takeda Revenue in Type 2 Diabetes Medicines Business (2019-2024) & (US$ Million)

Table 90. Takeda Recent Development

Table 91. Tonghua Dongbao Company Details

Table 92. Tonghua Dongbao Business Overview

Table 93. Tonghua Dongbao Type 2 Diabetes Medicines Product

Table 94. Tonghua Dongbao Revenue in Type 2 Diabetes Medicines Business (2019-2024) & (US$ Million)

Table 95. Tonghua Dongbao Recent Development

Table 96. United Pharmaceuticals Company Details

Table 97. United Pharmaceuticals Business Overview

Table 98. United Pharmaceuticals Type 2 Diabetes Medicines Product

Table 99. United Pharmaceuticals Revenue in Type 2 Diabetes Medicines Business (2019-2024) & (US$ Million)

Table 100. United Pharmaceuticals Recent Development

Table 101. Ganli Pharmaceutical Company Details

Table 102. Ganli Pharmaceutical Business Overview

Table 103. Ganli Pharmaceutical Type 2 Diabetes Medicines Product

Table 104. Ganli Pharmaceutical Revenue in Type 2 Diabetes Medicines Business (2019-2024) & (US$ Million)

Table 105. Ganli Pharmaceutical Recent Development

Table 106. Biocon Company Details

Table 107. Biocon Business Overview

Table 108. Biocon Type 2 Diabetes Medicines Product

Table 109. Biocon Revenue in Type 2 Diabetes Medicines Business (2019-2024) & (US$ Million)

Table 110. Biocon Recent Development

Table 111. Conker Pharmaceuticals Company Details

Table 112. Conker Pharmaceuticals Business Overview

Table 113. Conker Pharmaceuticals Type 2 Diabetes Medicines Product

Table 114. Conker Pharmaceuticals Revenue in Type 2 Diabetes Medicines Business (2019-2024) & (US$ Million)

Table 115. Conker Pharmaceuticals Recent Development

Table 116. Jiangsu Wanbang Company Details

Table 117. Jiangsu Wanbang Business Overview

Table 118. Jiangsu Wanbang Type 2 Diabetes Medicines Product

Table 119. Jiangsu Wanbang Revenue in Type 2 Diabetes Medicines Business (2019-2024) & (US$ Million)

Table 120. Jiangsu Wanbang Recent Development

Table 121. Geropharm Company Details

Table 122. Geropharm Business Overview

Table 123. Geropharm Type 2 Diabetes Medicines Product

Table 124. Geropharm Revenue in Type 2 Diabetes Medicines Business (2019-2024) & (US$ Million)

Table 125. Geropharm Recent Development

Table 126. Wockhardt Company Details

Table 127. Wockhardt Business Overview

Table 128. Wockhardt Type 2 Diabetes Medicines Product

Table 129. Wockhardt Revenue in Type 2 Diabetes Medicines Business (2019-2024) & (US$ Million)

Table 130. Wockhardt Recent Development

Table 131. Merck Serono Company Details

Table 132. Merck Serono Business Overview

Table 133. Merck Serono Type 2 Diabetes Medicines Product

Table 134. Merck Serono Revenue in Type 2 Diabetes Medicines Business (2019-2024) & (US$ Million)

Table 135. Merck Serono Recent Development

Table 136. Novartis Company Details

Table 137. Novartis Business Overview

Table 138. Novartis Type 2 Diabetes Medicines Product

Table 139. Novartis Revenue in Type 2 Diabetes Medicines Business (2019-2024) & (US$ Million)

Table 140. Novartis Recent Development

Table 141. Research Programs/Design for This Report

Table 142. Key Data Information from Secondary Sources

Table 143. Key Data Information from Primary Sources

Table 144. Authors List of This Report

List of Figures

Figure 1. Type 2 Diabetes Medicines Picture

Figure 2. Global Type 2 Diabetes Medicines Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Type 2 Diabetes Medicines Market Share by Type: 2023 VS 2030

Figure 4. Oral Hypoglycemic Medications Features

Figure 5. Insulin Injection Features

Figure 6. Global Type 2 Diabetes Medicines Market Size by Channel (2024-2030) & (US$ Million)

Figure 7. Global Type 2 Diabetes Medicines Market Share by Channel: 2023 VS 2030

Figure 8. Hospital Case Studies

Figure 9. Retail Pharmacy Case Studies

Figure 10. Type 2 Diabetes Medicines Report Years Considered

Figure 11. Global Type 2 Diabetes Medicines Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 12. Global Type 2 Diabetes Medicines Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 13. Global Type 2 Diabetes Medicines Market Share by Region: 2023 VS 2030

Figure 14. Global Type 2 Diabetes Medicines Market Share by Players in 2023

Figure 15. Global Top Type 2 Diabetes Medicines Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Type 2 Diabetes Medicines as of 2023)

Figure 16. The Top 10 and 5 Players Market Share by Type 2 Diabetes Medicines Revenue in 2023

Figure 17. North America Type 2 Diabetes Medicines Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 18. North America Type 2 Diabetes Medicines Market Share by Country (2019-2030)

Figure 19. United States Type 2 Diabetes Medicines Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 20. Canada Type 2 Diabetes Medicines Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. Europe Type 2 Diabetes Medicines Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Europe Type 2 Diabetes Medicines Market Share by Country (2019-2030)

Figure 23. Germany Type 2 Diabetes Medicines Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. France Type 2 Diabetes Medicines Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. U.K. Type 2 Diabetes Medicines Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. Italy Type 2 Diabetes Medicines Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. Russia Type 2 Diabetes Medicines Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Nordic Countries Type 2 Diabetes Medicines Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Asia-Pacific Type 2 Diabetes Medicines Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Asia-Pacific Type 2 Diabetes Medicines Market Share by Region (2019-2030)

Figure 31. China Type 2 Diabetes Medicines Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Japan Type 2 Diabetes Medicines Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. South Korea Type 2 Diabetes Medicines Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Southeast Asia Type 2 Diabetes Medicines Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. India Type 2 Diabetes Medicines Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Australia Type 2 Diabetes Medicines Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Latin America Type 2 Diabetes Medicines Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Latin America Type 2 Diabetes Medicines Market Share by Country (2019-2030)

Figure 39. Mexico Type 2 Diabetes Medicines Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Brazil Type 2 Diabetes Medicines Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Middle East & Africa Type 2 Diabetes Medicines Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Middle East & Africa Type 2 Diabetes Medicines Market Share by Country (2019-2030)

Figure 43. Turkey Type 2 Diabetes Medicines Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Saudi Arabia Type 2 Diabetes Medicines Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. UAE Type 2 Diabetes Medicines Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Novo Nordisk Revenue Growth Rate in Type 2 Diabetes Medicines Business (2019-2024)

Figure 47. Sanofi Revenue Growth Rate in Type 2 Diabetes Medicines Business (2019-2024)

Figure 48. Eli Lilly Revenue Growth Rate in Type 2 Diabetes Medicines Business (2019-2024)

Figure 49. Merck Revenue Growth Rate in Type 2 Diabetes Medicines Business (2019-2024)

Figure 50. AstraZeneca Revenue Growth Rate in Type 2 Diabetes Medicines Business (2019-2024)

Figure 51. bayer Revenue Growth Rate in Type 2 Diabetes Medicines Business (2019-2024)

Figure 52. Boehringer Ingelheim Revenue Growth Rate in Type 2 Diabetes Medicines Business (2019-2024)

Figure 53. Johnson & Johnson Revenue Growth Rate in Type 2 Diabetes Medicines Business (2019-2024)

Figure 54. Takeda Revenue Growth Rate in Type 2 Diabetes Medicines Business (2019-2024)

Figure 55. Tonghua Dongbao Revenue Growth Rate in Type 2 Diabetes Medicines Business (2019-2024)

Figure 56. United Pharmaceuticals Revenue Growth Rate in Type 2 Diabetes Medicines Business (2019-2024)

Figure 57. Ganli Pharmaceutical Revenue Growth Rate in Type 2 Diabetes Medicines Business (2019-2024)

Figure 58. Biocon Revenue Growth Rate in Type 2 Diabetes Medicines Business (2019-2024)

Figure 59. Conker Pharmaceuticals Revenue Growth Rate in Type 2 Diabetes Medicines Business (2019-2024)

Figure 60. Jiangsu Wanbang Revenue Growth Rate in Type 2 Diabetes Medicines Business (2019-2024)

Figure 61. Geropharm Revenue Growth Rate in Type 2 Diabetes Medicines Business (2019-2024)

Figure 62. Wockhardt Revenue Growth Rate in Type 2 Diabetes Medicines Business (2019-2024)

Figure 63. Merck Serono Revenue Growth Rate in Type 2 Diabetes Medicines Business (2019-2024)

Figure 64. Novartis Revenue Growth Rate in Type 2 Diabetes Medicines Business (2019-2024)

Figure 65. Bottom-up and Top-down Approaches for This Report

Figure 66. Data Triangulation

Figure 67. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Diabetes Treatment Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Type 2 Diabetes Medications Market Research Report 2024

Type 2 Diabetes Medication Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Hypoglycemic Drugs Market Insights Forecast to 2030

Global Medication for Diabetes Market Research Report 2024

Global Type 2 Diabetes Mellitus Treatment Market Research Report 2024

Diabetes Drug Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Injectable Drugs For Type 2 Diabete Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Diabetes Mellitus Treatment Market Insights Forecast to 2030

Injectable Drugs For Diabetes Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Diabetes Care Drugs Market Insights Forecast to 2030

Global Oral Antidiabetic OAD Treatment Market Research Report 2024

Oral Medicines for Diabetes Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Needle Free Diabetes Care Market Research Report 2024

Global Insulin Drugs for Diabetes Market Research Report 2024

Diabetes Treatment Device Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Diabetes Management Equipment Market Research Report 2024

Global Diabetic Foot Medicine Market Research Report 2025

Anti diabetic Medication Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions